Department of Health and Human Services
National Institutes of Health
Toggle navigation
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
Help & Search Tips
Contact Us
National Institute on Deafness and Other Communication Disorders (NIDCD)s
National Institute on Deafness and Other Communication Disorders (NIDCD)
10 Protocols (6 Active Accrual of new subjects, 4 Follow-up of previously enrolled subjects)
001560-DC:
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
001126-DC:
Collection of Clinical Data and Specimens for Research in Hearing, Balance and Communication Disorders
000141-DC:
Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets
21-DC-0002:
Phase II Interventional Study using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss among Individuals with Head and Neck Cancer
20-DC-0047:
Natural History of Autosomal Dominant Hearing Loss
12-DC-0152:
Normative Values in Audiovestibular Testing
17-DC-0138:
Observational Study of Hearing Loss and the Effects of Statin Drugs in Head and Neck Squamous Cell Carcinoma Patients Treated with Cisplatin Chemoradiation
01-DC-0229:
Genetic Analysis of Hereditary Disorders of Hearing and Balance
01-DC-0228:
Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts
97-DC-0057:
Genetic Studies of Stuttering